Infectious Causes Of Cancer: Targets For Intervention (infectious Disease)

Infectious Causes of Cancer Targets for Intervention Edited by JAMES J. GOEDERT, MD HUMANA PRESS Infectious Causes of Cancer I n f e c t i o u s . Di s e a s e SERIES EDITOR: Vassil St. Georgiev Infectious Causes of Cancer: Targets for Intervention, edited by James J. Goedert, 2000 Infectious Disease in the Aging: A Clinical Handbook, edited by Thomas T. Yoshikawa and Dean C. Norman, 2000 Management of Antimicrobials in Infectious Diseases, edited by Arch G. Mainous III and Claire Pomeroy, 2000 Infectious.Disease Infectious Causes of Cancer Targets for Intervention Edited by James J. Goedert, MD Viral Epidemiology Branch, National Cancer Institute Rockville, MD Humana Press Totowa, New Jersey © 2000 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey 07512 All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. All authored papers, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher or editor. Editing was performed in Dr. Goedert's private capacity and not as part of his official duties. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication. This publication is printed on acid-free paper. ' ANSI Z39.48-1984 (American Standards Institute) Permanence of Paper for Printed Library Materials. Cover design by Patricia F. Cleary. For additional copies, prici